NOVAVAX INC's ticker is NVAXXXXX and the CUSIP is 670002104. A total of 194 filers reported holding NOVAVAX INC in Q2 2016. The put-call ratio across all filers is 2.50 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2019 | $17,000 | -87.5% | 30,246 | -59.2% | 0.00% | – |
Q4 2018 | $136,000 | +248.7% | 74,126 | +260.2% | 0.00% | – |
Q3 2018 | $39,000 | -26.4% | 20,578 | -48.2% | 0.00% | – |
Q2 2018 | $53,000 | -14.5% | 39,753 | +35.6% | 0.00% | – |
Q1 2018 | $62,000 | +169.6% | 29,306 | +57.8% | 0.00% | – |
Q4 2016 | $23,000 | -78.5% | 18,568 | -64.1% | 0.00% | – |
Q3 2016 | $107,000 | -87.3% | 51,678 | -55.5% | 0.00% | -100.0% |
Q2 2016 | $845,000 | +105.6% | 116,224 | +46.0% | 0.00% | 0.0% |
Q1 2016 | $411,000 | -25.9% | 79,596 | +20.3% | 0.00% | 0.0% |
Q4 2015 | $555,000 | +320.5% | 66,155 | +254.6% | 0.00% | – |
Q3 2015 | $132,000 | -33.0% | 18,657 | +5.5% | 0.00% | – |
Q2 2015 | $197,000 | +87.6% | 17,677 | +39.2% | 0.00% | – |
Q1 2015 | $105,000 | -18.0% | 12,696 | -58.7% | 0.00% | – |
Q3 2014 | $128,000 | – | 30,740 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
BB BIOTECH AG | 8,330,000 | $10,496,000 | 0.39% |
Alden Global Capital LLC | 640,500 | $807,000 | 0.28% |
Quantitative Investment Management, LLC | 3,784,100 | $4,767,000 | 0.12% |
Eventide Asset Management | 1,449,700 | $1,827,000 | 0.12% |
Bellevue Group AG | 325,000 | $410,000 | 0.08% |
Virtus ETF Advisers LLC | 196,162 | $247,000 | 0.07% |
Rock Springs Capital Management LP | 820,000 | $1,033,000 | 0.07% |
Quantbot Technologies LP | 462,250 | $582,000 | 0.06% |
Traynor Capital Management, Inc. | 43,361 | $55,000 | 0.04% |
Tekla Capital Management LLC | 571,000 | $719,000 | 0.03% |